Tumor Lysis Syndrome following a Single Dose of Nivolumab for Relapsed Small-Cell Lung Cancer
Tumor lysis syndrome (TLS) is an oncologic emergency most frequently associated with initial treatment of hematologic malignancies and high-tumor burden solid tumors such as small-cell lung cancer (SCLC). Most often, TLS is associated with cytotoxic chemotherapy. In the treatment of SCLC, a paradigm...
Saved in:
Main Authors: | , , |
---|---|
Format: | article |
Language: | EN |
Published: |
Karger Publishers
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/7f3a540ff9c64291a6565598aaa03d70 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|